Found: 30
Select item for more details and to access through your institution.
Knockdown of lncRNA ZFAS1‐suppressed non–small cell lung cancer progression via targeting the miR‐150‐5p/HMGA2 signaling.
- Published in:
- Journal of Cellular Biochemistry, 2020, v. 121, n. 8/9, p. 3814, doi. 10.1002/jcb.29542
- By:
- Publication type:
- Article
Correction: MDM2 provides TOP2 poison resistance by promoting proteolysis of TOP2βcc in a p53-independent manner.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
MDM2 provides TOP2 poison resistance by promoting proteolysis of TOP2βcc in a p53-independent manner.
- Published in:
- Cell Death & Disease, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41419-024-06474-3
- By:
- Publication type:
- Article
Concordance Study of a 520-Gene Next-Generation Sequencing-Based Genomic Profiling Assay of Tissue and Plasma Samples.
- Published in:
- Molecular Diagnosis & Therapy, 2022, v. 26, n. 3, p. 309, doi. 10.1007/s40291-022-00579-1
- By:
- Publication type:
- Article
Regulatory Network Analysis of Mutated Genes Based on Multi-Omics Data Reveals the Exclusive Features in Tumor Immune Microenvironment Between Left-Sided and Right-Sided Colon Cancer.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.685515
- By:
- Publication type:
- Article
Lung Adenocarcinoma Harboring EGFR Kinase Domain Duplication (EGFR -KDD) Confers Sensitivity to Osimertinib and Nivolumab: A Case Report.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.575739
- By:
- Publication type:
- Article
In silico Method in CRISPR/Cas System: An Expedite and Powerful Booster.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.584404
- By:
- Publication type:
- Article
Targeted sequencing identifies the mutational signature of double primary and metastatic malignancies: a case report.
- Published in:
- Diagnostic Pathology, 2019, v. 14, n. 1, p. N.PAG, doi. 10.1186/s13000-019-0874-5
- By:
- Publication type:
- Article
YRDC is upregulated in non-small cell lung cancer and promotes cell proliferation by decreasing cell apoptosis.
- Published in:
- Oncology Letters, 2020, v. 20, n. 1, p. 43, doi. 10.3892/ol.2020.11560
- By:
- Publication type:
- Article
Hypermethylation of MDFI promoter with NSCLC is specific for females, non‑smokers and people younger than 65.
- Published in:
- Oncology Letters, 2018, v. 15, n. 6, p. 9017, doi. 10.3892/ol.2018.8535
- By:
- Publication type:
- Article
Comprehensive Analysis of APA Events and Their Association With Tumor Microenvironment in Lung Adenocarcinoma.
- Published in:
- Frontiers in Genetics, 2021, v. 11, p. N.PAG, doi. 10.3389/fgene.2021.645360
- By:
- Publication type:
- Article
Designing a general method for predicting the regulatory relationships between long noncoding RNAs and protein-coding genes based on multi-omics characteristics.
- Published in:
- Bioinformatics, 2020, v. 36, n. 7, p. 2025, doi. 10.1093/bioinformatics/btz886
- By:
- Publication type:
- Article
Research progress on the relationship between the TOR signaling pathway regulator, epigenetics, and tumor development.
- Published in:
- Frontiers in Genetics, 2022, v. 13, p. 01, doi. 10.3389/fgene.2022.1006936
- By:
- Publication type:
- Article
Dynamic Response Analysis of Steel-Concrete Beam Deck Pavement under Moving Load.
- Published in:
- Journal of Engineering Science & Technology Review, 2022, v. 15, n. 6, p. 132, doi. 10.25103/jestr.156.16
- By:
- Publication type:
- Article
ATM inhibitor KU60019 synergistically sensitizes lung cancer cells to topoisomerase II poisons by multiple mechanisms.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-28185-z
- By:
- Publication type:
- Article
ATM inhibitor KU60019 synergistically sensitizes lung cancer cells to topoisomerase II poisons by multiple mechanisms.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-28185-z
- By:
- Publication type:
- Article
Identification of novel gene signature for lung adenocarcinoma by machine learning to predict immunotherapy and prognosis.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1177847
- By:
- Publication type:
- Article
LncRNA RP11-805J14.5 functions as a ceRNA to regulate CCND2 by sponging miR-34b-3p and miR-139-5p in lung adenocarcinoma.
- Published in:
- Oncology Reports, 2022, v. 48, n. 3, p. N.PAG, doi. 10.3892/or.2022.8376
- By:
- Publication type:
- Article
Identification of hypoxia‐related gene signatures based on multi‐omics analysis in lung adenocarcinoma.
- Published in:
- Journal of Cellular & Molecular Medicine, 2024, v. 28, n. 2, p. 1, doi. 10.1111/jcmm.18032
- By:
- Publication type:
- Article
Network analysis of KLF5 targets showing the potential oncogenic role of SNHG12 in colorectal cancer.
- Published in:
- Cancer Cell International, 2020, v. 20, n. 1, p. N.PAG, doi. 10.1186/s12935-020-01527-x
- By:
- Publication type:
- Article
LncRNA FOXD3-AS1 promoted chemo-resistance of NSCLC cells via directly acting on miR-127-3p/MDM2 axis.
- Published in:
- Cancer Cell International, 2020, v. 20, n. 1, p. 1, doi. 10.1186/s12935-020-01402-9
- By:
- Publication type:
- Article
Knockdown of TOR signaling pathway regulator suppresses cell migration and invasion in non-small cell lung cancer via the regulation of epithelial-to-mesenchymal transition.
- Published in:
- Experimental & Therapeutic Medicine, 2020, v. 19, n. 3, p. 1925, doi. 10.3892/etm.2019.8358
- By:
- Publication type:
- Article
Genome-wide identification of WRKY transcription factor family members in Miscanthus sinensis (Miscanthus sinensis Anderss).
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-55849-1
- By:
- Publication type:
- Article
ATM inhibitor KU60019 synergistically sensitizes lung cancer cells to topoisomerase II poisons by multiple mechanisms.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-28185-z
- By:
- Publication type:
- Article
Author Correction: ATM inhibitor KU60019 synergistically sensitizes lung cancer cells to topoisomerase II poisons by multiple mechanisms.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Author Correction: ATM inhibitor KU60019 synergistically sensitizes lung cancer cells to topoisomerase II poisons by multiple mechanisms.
- Published in:
- 2023
- By:
- Publication type:
- Product Review
ATM inhibitor KU60019 synergistically sensitizes lung cancer cells to topoisomerase II poisons by multiple mechanisms.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-28185-z
- By:
- Publication type:
- Article
Identification of EGFR mutation status in male patients with non-small-cell lung cancer: role of <sup>18</sup>F-FDG PET/CT and serum tumor markers CYFRA21-1 and SCC-Ag.
- Published in:
- EJNMMI Research, 2023, v. 13, n. 1, p. 1, doi. 10.1186/s13550-023-00976-5
- By:
- Publication type:
- Article
Osimertinib confers potent binding affinity to EGFR kinase domain duplication.
- Published in:
- International Journal of Cancer, 2019, v. 145, n. 10, p. 2884, doi. 10.1002/ijc.32617
- By:
- Publication type:
- Article
Application of mediastinal drainage tube in intrathoracic esophageal anastomotic leakage for early diagnosis and effective treatment: a retrospective study.
- Published in:
- 2021
- By:
- Publication type:
- journal article